Frank D. Lee Net Worth

Track Major Insider Updates On X/Twitter

Last Updated: 4 months, 3 weeks ago

Frank D. Lee has an estimated net worth of at least $10.3 million*, as of Oct. 15, 2025. They own 399,012 shares of PCRX stock. They have sold 33,893 shares of PCRX stock since 2021, for an estimated $-99,994.

Frank D. Lee $PCRX SEC Form 4 Insider Trading

Frank D. Lee has filed a total of 1 insider trades in $PCRX since 2021. Their most recent trade was a purchase of 8,264 shares, made on Aug 12, 2024. Their largest trade was a purchase of 8,264 shares, made on Aug 12, 2024. We estimate that they now own 399,012 shares of $PCRX, worth an estimated $10.4 million.

Insider Trading at $PCRX

There have been a total of 147 insider trades reported at $PCRX since 2021, with 17,576 shares purchased and 597,536 shares sold. The most active insider traders in $PCRX stock have been Kristen Marie Williams, Roy Winston, and Max Reinhardt. The most recent trade was a sale of 4,000 shares reported by LAUREN RIKER (Senior Vice President, Finance), made on Feb 02, 2026.

History of Insider Stock Trades by Frank D. Lee

Company Ticker	Purchase / Sale	Shares	Date	Disclosed (EST)
BHC	Sale	15,912	Aug 21, 2025	Aug. 22, 2025, 4:19 p.m.
PCRX	Purchase	8,264	Aug 12, 2024	Aug. 13, 2024, 4:55 p.m.
FMTX	Sale	17,981	Feb 23, 2022	Feb. 25, 2022, 6:08 p.m.

$PCRX Executives and Stock Owners with Insider Trades

Kristen Marie Williams, Chief Administrative Officer
Roy Winston, Chief Medical Officer
Max Reinhardt, President, Rest of World
Anthony Molloy, Chief Lgl & Compliance Officer
Lauren Bullaro Riker, Senior Vice President, Finance
Daryl Gaugler, Chief Operating Officer
David M Stack, CEO and Chairman
Charles Anthony Laranjeira, Chief Technical Officer
Jonathan Slonin, Chief Clinical Officer
Jonathan Slonin, Chief Medical Officer
Lauren Bullaro Riker, Vice President, Finance
Charles A. Iii Reinhart, Chief Financial Officer
Dennis Mcloughlin, Chief Customer Officer
Lauren Riker, Senior Vice President, Finance
Kristen Williams, Chief Administrative Officer
Shawn Cross, Chief Financial Officer
Donald C. Manning, Chief Medical Officer
Ronald J. Jr. Ellis, Chief Strategy Officer
Frank D. Lee, Chief Executive Officer
Roy Winston, Chief Clinical Officer

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.